Unknown

Dataset Information

0

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.


ABSTRACT: While molecular subtypes of glioblastoma (GBM) are defined using gene expression and mutation profiles, we identify a unique subpopulation based on addiction to the high-affinity glucose transporter, Glut3. Although Glut3 is a known driver of a cancer stem cell phenotype, direct targeting is complicated by its expression in neurons. Using established GBM lines and patient-derived stem cells, we identify a subset of tumors within the "proneural" and "classical" subtypes that are addicted to aberrant signaling from integrin ?v?3, which activates a PAK4-YAP/TAZ signaling axis to enhance Glut3 expression. This defined subpopulation of GBM is highly sensitive to agents that disrupt this pathway, including the integrin antagonist cilengitide, providing a targeted therapeutic strategy for this unique subset of GBM tumors.

SUBMITTER: Cosset E 

PROVIDER: S-EPMC5730343 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


While molecular subtypes of glioblastoma (GBM) are defined using gene expression and mutation profiles, we identify a unique subpopulation based on addiction to the high-affinity glucose transporter, Glut3. Although Glut3 is a known driver of a cancer stem cell phenotype, direct targeting is complicated by its expression in neurons. Using established GBM lines and patient-derived stem cells, we identify a subset of tumors within the "proneural" and "classical" subtypes that are addicted to aberr  ...[more]

Similar Datasets

| S-EPMC6551209 | biostudies-literature
| S-EPMC9374336 | biostudies-literature
| S-EPMC8661409 | biostudies-literature
| S-EPMC11236193 | biostudies-literature
| S-EPMC3593379 | biostudies-other
2020-12-29 | GSE163906 | GEO
2020-12-04 | MSV000086560 | MassIVE
| S-EPMC9545988 | biostudies-literature
| S-EPMC9297035 | biostudies-literature
| S-EPMC7877538 | biostudies-literature